Income Statement (TTM)
Sino Biopharmaceutical Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23,039 | 23,647 | 24,668 | 25,353 | 26,129 | 26,861 | 27,215 | 27,701 | 28,241 | 26,026 | 25,571 | 25,116 | 26,199 | 26,995 | 27,790 | 28,866 | 29,716 | 30,567 |
| Change (%) | 2.64 | 4.32 | 2.78 | 3.06 | 2.80 | 1.32 | 1.79 | 1.95 | -7.84 | -1.75 | -1.78 | 4.31 | 3.04 | 2.95 | 3.87 | 2.95 | 2.86 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 5,230 | 5,182 | 5,331 | 5,143 | 5,150 | 5,332 | 5,396 | 5,539 | 5,667 | 4,488 | 4,308 | 4,128 | 4,990 | 5,112 | 5,235 | 5,336 | 5,454 | 5,573 |
| Change (%) | -0.91 | 2.87 | -3.52 | 0.13 | 3.53 | 1.20 | 2.64 | 2.32 | -20.81 | -4.01 | -4.18 | 20.89 | 2.46 | 2.40 | 1.94 | 2.21 | 2.17 | |
| % of Revenue | 22.70 | 21.92 | 21.61 | 20.29 | 19.71 | 19.85 | 19.83 | 19.99 | 20.07 | 17.24 | 16.85 | 16.43 | 19.05 | 18.94 | 18.84 | 18.49 | 18.35 | 18.23 |
| Gross Operating Profit | 17,809 | 18,465 | 19,337 | 20,210 | 20,979 | 21,529 | 21,819 | 22,163 | 22,574 | 21,539 | 21,263 | 20,988 | 21,210 | 21,882 | 22,555 | 23,530 | 24,262 | 24,994 |
| Change (%) | 3.68 | 4.72 | 4.51 | 3.80 | 2.62 | 1.35 | 1.58 | 1.85 | -4.59 | -1.28 | -1.29 | 1.05 | 3.17 | 3.07 | 4.32 | 3.11 | 3.02 | |
| % of Revenue | 77.30 | 78.08 | 78.39 | 79.71 | 80.29 | 80.15 | 80.17 | 80.01 | 79.93 | 82.76 | 83.15 | 83.57 | 80.95 | 81.06 | 81.16 | 81.51 | 81.65 | 81.77 |
| SG&A | 11,254 | 11,629 | 12,198 | 12,754 | 12,718 | 12,704 | 12,669 | 12,846 | 12,705 | 11,709 | 11,355 | 11,001 | 11,067 | 11,378 | 11,689 | 12,159 | 12,507 | 12,855 |
| Change (%) | 3.33 | 4.90 | 4.56 | -0.28 | -0.11 | -0.27 | 1.39 | -1.10 | -7.84 | -3.02 | -3.12 | 0.60 | 2.81 | 2.73 | 4.03 | 2.86 | 2.78 | |
| % of Revenue | 48.85 | 49.18 | 49.45 | 50.31 | 48.67 | 47.29 | 46.55 | 46.37 | 44.99 | 44.99 | 44.40 | 43.80 | 42.24 | 42.15 | 42.06 | 42.12 | 42.09 | 42.06 |
| R&D | ||||||||||||||||||
| Change (%) | ||||||||||||||||||
| % of Revenue | ||||||||||||||||||
| OpEx | 18,817 | 19,549 | 20,366 | 20,707 | 21,722 | 22,228 | 22,244 | 22,928 | 22,914 | 20,640 | 20,247 | 19,853 | 20,760 | 21,340 | 21,920 | 23,065 | 23,946 | 24,827 |
| Change (%) | 3.89 | 4.18 | 1.67 | 4.90 | 2.33 | 0.07 | 3.08 | -0.06 | -9.92 | -1.91 | -1.94 | 4.57 | 2.79 | 2.72 | 5.22 | 3.82 | 3.68 | |
| % of Revenue | 81.67 | 82.67 | 82.56 | 81.67 | 83.13 | 82.75 | 81.73 | 82.77 | 81.14 | 79.31 | 79.18 | 79.05 | 79.24 | 79.05 | 78.88 | 79.90 | 80.58 | 81.22 |
| Operating Income | 4,222 | 4,098 | 4,302 | 4,646 | 4,407 | 4,633 | 4,971 | 4,773 | 5,327 | 5,386 | 5,324 | 5,263 | 5,439 | 5,655 | 5,870 | 5,801 | 5,771 | 5,740 |
| Change (%) | -2.94 | 4.97 | 8.00 | -5.15 | 5.13 | 7.30 | -3.99 | 11.61 | 1.11 | -1.14 | -1.15 | 3.35 | 3.96 | 3.81 | -1.18 | -0.53 | -0.53 | |
| % of Revenue | 18.33 | 17.33 | 17.44 | 18.33 | 16.87 | 17.25 | 18.27 | 17.23 | 18.86 | 20.69 | 20.82 | 20.95 | 20.76 | 20.95 | 21.12 | 20.10 | 19.42 | 18.78 |
| Interest Expense | -362 | -323 | -305 | -296 | -286 | -309 | -322 | -331 | -385 | -429 | -492 | -554 | -495 | -425 | -356 | -295 | -280 | -265 |
| Change (%) | -10.70 | -5.80 | -2.74 | -3.52 | 7.97 | 4.20 | 2.82 | 16.39 | 11.60 | 14.45 | 12.63 | -10.55 | -14.10 | -16.42 | -17.00 | -5.17 | -5.46 | |
| % of Revenue | -1.57 | -1.37 | -1.23 | -1.17 | -1.09 | -1.15 | -1.18 | -1.19 | -1.36 | -1.65 | -1.92 | -2.20 | -1.89 | -1.58 | -1.28 | -1.02 | -0.94 | -0.87 |
| Net Income | 2,302 | 2,771 | 3,809 | 10,011 | 12,465 | 14,608 | 13,655 | 8,049 | 5,296 | 2,544 | 2,212 | 1,881 | 2,332 | 3,211 | 4,090 | 3,500 | 3,686 | 3,871 |
| Change (%) | 20.39 | 37.45 | 162.83 | 24.51 | 17.20 | -6.52 | -41.06 | -34.20 | -51.97 | -13.02 | -14.97 | 23.95 | 37.70 | 27.38 | -14.44 | 5.31 | 5.04 | |
| % of Revenue | 9.99 | 11.72 | 15.44 | 39.49 | 47.71 | 54.38 | 50.18 | 29.06 | 18.75 | 9.77 | 8.65 | 7.49 | 8.90 | 11.90 | 14.72 | 12.12 | 12.40 | 12.67 |
Source: Capital IQ
